Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Wayne Brinster Joins WHEATON® as President

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.

WHEATON has announced the appointment of Wayne Brinster to the role of president, succeeding Stephen R, Drozdow, who remains as chief executive officer.

Mr. Brinster brings to the position a familiar, science-driven focus while sharing Mr. Drozdow’s long-time commitment to WHEATON customers, suppliers, partners and employees.

Mr. Brinster comes to WHEATON from Synthon Pharmaceuticals, a privately owned manufacturer of pharmaceutical and biopharmaceutical products, where he served as vice president and general manager.

Prior to Synthon, Mr. Brinster worked in different management roles for over 30 years at Becton, Dickinson and Company, where he most recently led the BD Diagnostics Women’s Health and Cancer Care initiative.

“Having spent most of my life in the business of science, I am excited to be here with a leading name in the field, joining an organization that has developed a reputation for supporting important scientific achievements,” said Mr. Brinster.

“By leveraging technical knowledge with excellent customer service, we’re going to continue placing WHEATON at the forefront of the industry,” he added.

Mr. Drozdow, after leading WHEATON since 1996, will become the chief executive officer and will continue to have an active role at WHEATON, working closely with Mr. Brinster on matters pertaining to strategy, key industry relationships, finance, budgets and acquisitions. “Wayne is a great business leader,” said Mr. Drozdow. “He understands the science of our markets, knows our industry and identifies with our approach to customers.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Potential Urine Test for CJD
Researchers at the Medical Research Council (MRC) Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos